Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nitric oxide

EU orphan designation number: EU/3/13/1209   
Active ingredient: Nitric oxide
Indication: Treatment of cystic fibrosis
Sponsor: Novoteris
Diamantstraat 8, 2200 Herentals, BelgiŽ

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2013 Centralised Orphan - Designation EMA/OD/095/13 (2013)9697 of 18/12/2013